Company news
Dsm-firmenich Ag (EURONEXT:DSFIR) news
Dsm-firmenich Ag news releases on 6ix. Latest, Aug 18, 2026: Dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas…
Press releases & updates
Dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen’s decision to retire
August 18, 2026
Dsm-firmenich reports H1 2026 results
July 30, 2026
Dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S.
June 10, 2026
Dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam
May 21, 2026
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2026
May 7, 2026
dsm-firmenich Q1 2026 trading update
May 6, 2026
Weekly progress on share repurchase program to cover share plans and reduce capital
April 28, 2026
dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation
March 12, 2026
dsm-firmenich announces share repurchase program to cover share plans and reduce capital
March 12, 2026
dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program
February 26, 2026
dsm-firmenich publishes 2025 Integrated Annual Report
February 20, 2026
dsm-firmenich issues €1.5 billion long-term bonds
February 17, 2026
dsm-firmenich reports full year 2025 results
February 12, 2026
dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)
February 9, 2026
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners
February 9, 2026
dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer
January 14, 2026
dsm-firmenich completes €1.08 billion share repurchase program
December 2, 2025
dsm-firmenich Q3 2025 trading update
October 30, 2025
dsm-firmenich achieves target of 100% purchased renewable electricity
September 3, 2025
dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company
September 1, 2025
dsm-firmenich reports H1 2025 results
July 31, 2025
dsm-firmenich announces redemption of €750 million hybrid bond
July 1, 2025
dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion
June 27, 2025
dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion
June 2, 2025
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025
May 6, 2025
dsm-firmenich Q1 2025 trading update
April 30, 2025